XRTX — XORTX THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 4 SEC-registered investment managers reported holding XRTX (XORTX THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $35.98K across 17.19K shares. That is +0.1% by share count (+25 shares) versus the previous quarter, while reported value moved -10.1%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 added to existing stakes, 1 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of XORTX THERAPEUTICS INC (XRTX) include ARMISTICE CAPITAL, LLC, BANK OF MONTREAL /CAN/, Citadel Advisors, ranked by reported 13F value among the 20 institutional holders on this page.
XRTX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 4 | 17.19K | $35.98K | +0.1% |
| Q2 2026 | 6 | 40.44K | $92.84K | -80.2% |
| Q1 2026 | 3 | 15.32K | $6.25K | +0.0% |
| Q4 2025 | 5 | 37.10K | $14.76K | +228.4% |
| Q3 2025 | 5 | 100.66K | $81.47K | +45.9% |
| Q2 2025 | 6 | 64.63K | $60.19K | +833.7% |
| Q1 2025 | 2 | 451 | $416 | -76.1% |
| Q4 2024 | 6 | 286.96K | $324.39K | -9.7% |
Over the 8 quarters shown, institutional share counts decreased 94% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2025 (+833.7%).
Top Institutional Holders (Q3 2026) — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 15.97K | $33.87K | 0.00% | Reduce | |
| 1.15K | $2.00K | 0.00% | Add | |
| 55 | $93 | 0.00% | Hold | |
| 9 | $15 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 23.12K | $52.47K | 0.00% | New | |
| 16.37K | $37.90K | 0.00% | New | |
| 732 | $2.00K | 0.00% | New | |
| 162 | $329 | 0.00% | New | |
| 55 | $120 | 0.00% | Reduce | |
| 9 | $19 | 0.00% | Reduce |
Q1 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 15.00K | $6.13K | 0.00% | New | |
| 277 | $92 | 0.00% | Hold | |
| 47 | $19 | 0.00% | New |
Q4 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.60K | $7.08K | 0.00% | New | |
| 18.73K | $4.74K | 0.00% | New | |
| 4.09K | $2.00K | 0.00% | New | |
| 1.40K | $787 | 0.00% | Add | |
| 277 | $156 | 0.00% | Hold |
Q3 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 86.33K | $69.87K | 0.00% | Add | |
| 13.82K | $11.19K | 0.00% | New | |
| 277 | $225 | 0.00% | Hold | |
| 234 | $190 | 0.00% | Reduce | |
| 1 | $1 | 0.00% | New |
Q2 2025 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 38.47K | $35.77K | 0.00% | New | |
| 20.79K | $18.82K | 0.00% | New | |
| 3.93K | $3.90K | 0.00% | Add | |
| 663 | $1.00K | 0.00% | New | |
| 500 | $453 | 0.00% | New | |
| 277 | $251 | 0.00% | Hold |
New Positions (Q3 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Citadel Advisors sold 23.12K sh · $52.47K
- NATIONAL BANK OF CANADA /FI/ sold 162 sh · $329
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| StoneX Group Inc. | 15.97K | 16.37K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ROYAL BANK OF CANADA | 1.15K | 732 | — | 4.09K | — | 663 | — | 1.49K | 672 | 1.23K | — | 523 | — | — | — | — | — | — | — | — |
| Clearstead Advisors, LLC | 55 | 55 | 277 | 277 | 277 | 277 | 277 | 277 | 277 | 277 | 277 | 277 | 2.50K | — | — | — | — | — | — | — |
| TD Waterhouse Canada Inc. | 9 | 9 | 47 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | — | — | — | — | — | — | 265.00K | — | — | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | — | 23.12K | — | — | 86.33K | 38.47K | — | — | — | 12.33K | — | — | — | 28.11K | — | 17.64K | — | — | — | — |
| BANK OF MONTREAL /CAN/ | — | — | — | — | — | — | — | — | — | — | 14.99K | — | — | — | — | — | — | — | — | — |
| UBS Group AG | — | — | — | 1.40K | 234 | 20.79K | — | 17.43K | 18.78K | — | — | — | — | — | — | 66 | — | 5.70K | 3.70K | 1.11K |
| XTX Topco Ltd | — | — | — | — | 13.82K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TWO SIGMA SECURITIES, LLC | — | — | — | 12.60K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | — | — | — | — | — | — | — | 1.15K | 1.15K | 1.15K | 1.15K | 1.15K | 10.38K | — | — | — | — | — | — | — |
| Kingsview Wealth Management, LLC | — | — | 15.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NATIONAL BANK OF CANADA /FI/ | — | 162 | — | — | — | 3.93K | 174 | 1.61K | 3.44K | — | — | — | — | — | — | — | — | — | — | — |
| Baader Bank Aktiengesellschaft | — | — | — | 18.73K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | 254 | 254 | 254 | — | — | — | — | — | — | — | — | — |
| RAYMOND JAMES FINANCIAL INC | — | — | — | — | — | 500 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TORONTO DOMINION BANK | — | — | — | — | — | — | — | — | — | — | — | — | 53 | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | — | — | — | — | — | — | — | — | 84 | — | — | — | — | — | — | — | — | — | — | — |
| Bank of America Corp | — | — | — | — | — | — | — | — | — | — | — | — | 2 | 2 | 2 | 2 | 225 | 2 | 2 | 2 |
| SBI Securities Co., Ltd. | — | — | — | — | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold XRTX?
As of 2026-Q3, 4 institutional funds reported holding XRTX (XORTX THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $35.98K.
How many shares of XRTX do institutions own?
13F filers reported 17.19K shares of XRTX, worth $35.98K in aggregate at the end of 2026-Q3.
Is institutional ownership of XRTX rising or falling?
Share counts moved +0.1% versus the prior quarter — accumulation.
Who are the top institutional holders of XRTX?
The largest 13F holders are ARMISTICE CAPITAL, LLC, BANK OF MONTREAL /CAN/, Citadel Advisors, StoneX Group Inc., XTX Topco Ltd; the top 25 are ranked at the top of this page.
Who are the major shareholders of XORTX THERAPEUTICS INC?
The major shareholders of XORTX THERAPEUTICS INC (XRTX) by reported 13F value are ARMISTICE CAPITAL, LLC, BANK OF MONTREAL /CAN/, Citadel Advisors, StoneX Group Inc., XTX Topco Ltd, among 20 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.